
Sign up to save your podcasts
Or


The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
By Medscape4.9
849849 ratings
The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]

136 Listeners

319 Listeners

496 Listeners

170 Listeners

13 Listeners

17 Listeners

291 Listeners

3,344 Listeners

140 Listeners

1,159 Listeners

61 Listeners

195 Listeners

513 Listeners

364 Listeners

60 Listeners

27 Listeners

8 Listeners

252 Listeners

430 Listeners

369 Listeners